Danaher Corporation
Danaher is a leading global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. With a culture rooted in continuous improvement through the Danaher Business System, the company focuses on delivering innovation at the speed of life across various sectors including biotechnology, diagnostics, and biopharmaceuticals. Danaher partners with academia, industry, and public sector organizations to develop and deploy advanced technologies, aiming to make healthcare more accessible, precise, and effective. The company’s mission is to help solve complex health challenges and improve quality of life worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037
Products
Enterprise R&D data platform
Software product that organizes experimental and process data into structured, AI-ready formats to accelerate discovery and bioprocess optimization.
Automated cell-culture platform for 3D biology
Instrument platform that automates organoid and 3D culture workflows to improve reproducibility and throughput for drug discovery and toxicology studies.
High-sensitivity clinical immunoassay platform
Analytical platform engineered to detect very low-abundance protein biomarkers in blood to support earlier detection of neurodegenerative and other diseases.
Companion diagnostic assay development and clinical validation support
Services to standardize research assays for clinical labs, convert assays into deployable formats, and run prospective validation and clinical trials to establish thresholds and clinical utility.
Enterprise R&D data platform
Software product that organizes experimental and process data into structured, AI-ready formats to accelerate discovery and bioprocess optimization.
Automated cell-culture platform for 3D biology
Instrument platform that automates organoid and 3D culture workflows to improve reproducibility and throughput for drug discovery and toxicology studies.
High-sensitivity clinical immunoassay platform
Analytical platform engineered to detect very low-abundance protein biomarkers in blood to support earlier detection of neurodegenerative and other diseases.
Companion diagnostic assay development and clinical validation support
Services to standardize research assays for clinical labs, convert assays into deployable formats, and run prospective validation and clinical trials to establish thresholds and clinical utility.
Services
End-to-end service providing plasmid template production, mRNA synthesis and purification, lipid-nanoparticle encapsulation, analytical release testing and automated sterile filling.
cGMP-compliant manufacturing services for therapeutic oligonucleotides and guide RNAs with process knowledge to support clinical programs.
Collaborative centers that co-locate academic investigators and industry technology to accelerate target validation, assay development, and translational studies.
Deployment and integration of scalable software platforms that structure laboratory and R&D data into AI-ready formats and connect to automation systems.
Automation and scalable expansion of 3D organoid lines to support high-throughput drug screening and preclinical safety testing.
Slide digitization, image storage/management and AI-enabled analysis to support quantitative pathology and diagnostic assay development.
End-to-end service providing plasmid template production, mRNA synthesis and purification, lipid-nanoparticle encapsulation, analytical release testing and automated sterile filling.
cGMP-compliant manufacturing services for therapeutic oligonucleotides and guide RNAs with process knowledge to support clinical programs.
Collaborative centers that co-locate academic investigators and industry technology to accelerate target validation, assay development, and translational studies.
Deployment and integration of scalable software platforms that structure laboratory and R&D data into AI-ready formats and connect to automation systems.
Automation and scalable expansion of 3D organoid lines to support high-throughput drug screening and preclinical safety testing.
Slide digitization, image storage/management and AI-enabled analysis to support quantitative pathology and diagnostic assay development.
Expertise Areas
- mRNA and nucleic-acid therapeutic manufacturing
- Gene editing and CRISPR therapy platform development
- Spatial biology and spatialomics modeling
- Digital pathology and AI-driven diagnostics
Key Technologies
- mRNA manufacturing and lipid-nanoparticle encapsulation
- Plasmid DNA production
- CRISPR-based gene editing
- Next-generation sequencing (NGS)
News & Updates
Danaher employs continuous improvement through kaizen events involving associates at all levels to achieve significant operational improvements.
A strategic partnership with the University of Pennsylvania focusing on cell therapy manufacturing challenges to develop new technologies for better clinical outcomes.
Danaher discusses the challenges and opportunities in making diagnostics more accessible, reimbursable, and integrated into healthcare systems.
Danaher highlights the need for advanced diagnostics and AI to improve disease detection and treatment, especially in pathology.
Danaher explores how AI and data analytics are transforming diagnostics, enabling faster, more accurate, and more accessible healthcare.
Danaher addresses challenges in physician behavior, reimbursement, and evidence generation to accelerate adoption of new diagnostics.
Danaher employs continuous improvement through kaizen events involving associates at all levels to achieve significant operational improvements.
A strategic partnership with the University of Pennsylvania focusing on cell therapy manufacturing challenges to develop new technologies for better clinical outcomes.
Danaher discusses the challenges and opportunities in making diagnostics more accessible, reimbursable, and integrated into healthcare systems.
Danaher highlights the need for advanced diagnostics and AI to improve disease detection and treatment, especially in pathology.
Danaher explores how AI and data analytics are transforming diagnostics, enabling faster, more accurate, and more accessible healthcare.
Danaher addresses challenges in physician behavior, reimbursement, and evidence generation to accelerate adoption of new diagnostics.